Asian Star Company Ltd
ASTARAsian Star Company Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the P/E sits at the 73rd percentile of its own range — the multiple has already done part of the work.
The price is topping out (4 weeks in) while the P/E sits at the 73rd percentile of its own 10-year range. Underneath, the last four quarters read mixed, and 159% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Asian Star Company Ltd trades at ₹595, losing momentum at the top and 4 weeks into that stage. That is −5.1% against its own 200-day average. It sits at 9% of a 52-week range of ₹580 to ₹744. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (6 weeks and counting).
Today the stock is losing momentum at the top — week 4 of stage 3, confirmed. At ₹595 it trades −5.1% versus its 200-day average and sits at 9% of its 52-week range (₹580–₹744).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved −13% while the NIFTY 500 moved +264% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (6 weeks and counting; last ahead the week of 2026-06-25) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Asian Star Company Ltd trades at 23.6× P/E, at the pricey end of its own range (73rd percentile). Its long-run median P/E is 16.5×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 23.6× is at the pricey end of its own range (73rd percentile), against a long-run median of 16.5× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved −6.4% against a −18.5% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the −7.9%/yr price move, ~−9.7%/yr came from earnings growth and ~+1.8 pp from the multiple (expanding); over 10y, of the −3.1%/yr price move, ~−5.8%/yr came from earnings growth and ~+2.7 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Asian Star Company Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −38.9% at the trough to −15.6% off a 3-quarter-old trough (single-quarter readings), ROCE slipping at 4.0%. The read is built from 10 quarters across 3 curves, on partial evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −2.5% | −13.7% | +2.5% | −1.4% |
| Profit | −4.8% | −21.6% | −9.0% | −6.0% |
| EPS | −6.4% | −21.2% | −8.8% | −5.9% |
| Share price | −18.5% | −6.0% | −7.9% | −3.1% |
4-Factor Sector Score
27.8/100 — rank 23 of 26 in Diamond, Gems & Jewellery · 75% evidence confidence
Asian Star Company Ltd scores 27.8 out of 100 against the 26 companies it is compared with in Diamond, Gems & Jewellery, ranking 23. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 12 + 7.2 + 6.8 + 1.8 = 27.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Asian Star Company Ltd reported ₹746 Cr of revenue in the Mar 26 quarter, −12.7% year on year. Over 10 years it has compounded at −1.4% a year. The last full year, FY26, came in at ₹2,882 Cr. The last four reported quarters add to ₹2,882 Cr.
FY26 revenue came in at ₹2,882 Cr (−2.5% on the year), capping 10 years at −1.4% compound. The latest quarter (Mar 26) printed ₹746 Cr, −12.7% year on year.
Pace check: the last four quarters averaged −1.6% growth against the decade's −1.4% — the current year is running in line with its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −2.5% over the last 4 quarters against −9.6%/yr over the last 8 — accelerating; TTM profit −2.5% vs −27.8%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Asian Star Company Ltd's operating margin is 0.8% in the Mar 26 quarter, +0.2 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 2.2% to 5.0%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is 0.8%, +0.2 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 2.2%–5.0%.
Why the margin moved: operating margin went +0.2 pp year on year while gross margin went −0.3 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Asian Star Company Ltd posted a net loss of ₹0.4 Cr in the Mar 26 quarter. Full-year FY26 profit was ₹40.0 Cr. The 10-year compound rate is −6.0%. That loss is 0.1% of the quarter's revenue. The same quarter a year earlier lost ₹6.1 Cr. 2 of the last 12 reported quarters were loss-making.
Mar 26 profit was ₹−0.4 Cr, null year on year. On the full year, FY26 printed ₹40.0 Cr (−4.8%), and the 10-year compound rate is −6.0%.
Pace comparison, last four quarters: profit −13.7% vs revenue −1.6%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 159% of Asian Star Company Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹90.0 Cr of operating cash against ₹40.0 Cr of profit. After ₹4.0 Cr of capital spending, ₹86.0 Cr was left as free cash.
FY26: operating cash of ₹90.0 Cr against reported profit of ₹40.0 Cr, leaving free cash of ₹86.0 Cr after ₹4.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 159% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 159%: the cash cycle stretched 28 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Asian Star Company Ltd's cash conversion cycle runs 188 days in FY26, up from 160 days in FY21. Capital spending ran ₹21.0 Cr over the last 3 years. At FY26 sales of ₹2,882 Cr each day of that cycle holds about ₹7.9 Cr, so roughly ₹1,484 Cr sits inside the business at any moment.
FY26: debtors at 112 days, inventory at 111 days — roughly 3.7 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 188 days, looser than FY21's 160.
The full loop: cash goes out to suppliers and production on day 0; stock waits 111 days to sell; customers pay about 112 days after that; and suppliers themselves are paid at 35 days — netting out to the 188-day cycle.
In money terms: at FY26 sales of ₹2,882 Cr, each day of the cycle holds about ₹7.9 Cr — so the 188-day loop keeps roughly ₹1,484 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹21.0 Cr over the last 3 fiscal years against ₹33.0 Cr of depreciation — spending at or below maintenance level. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Asian Star Company Ltd earns a ROCE of 4% in FY26. That is up from a trough of 4% in FY21. Return on invested capital clears the cost of that capital by −9.5 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 1.4% net margin on 1.17× asset turns.
FY26 ROCE is 4%, recovered from a FY21 trough of 4% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 1.4% net margin × 1.17× asset turns × 1.49× balance-sheet leverage ≈ 2.4% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 2.5% − 12.0% = a −9.5 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Asian Star Company Ltd carries total debt of ₹493 Cr against shareholder equity of ₹1,658 Cr as of Mar 26, a debt-to-equity of 0.30 — effectively unlevered. On the annual view that ratio went from 0.53 in FY22 to 0.30 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹493 Cr against shareholder equity of ₹1,658 Cr — a debt-to-equity of 0.30. On the annual view, debt-to-equity went from 0.53 (FY22) to 0.30 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Asian Star Company Ltd moved a full percentage point over the last two years — the register is quiet. Domestic institutions moved +0.0 points over the same window, to 4.2%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +0.0 points over 8 quarters to 74.7%; Domestic institutions: +0.0 points over 8 quarters to 4.2%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Asian Star Company Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Tribhovandas Bhimji Zaveri LtdTBZ | 77.9/100Favorable setup83% evidence | BREAKING OUT | 28.0/35 Revenue 22.3% · PAT 100% · OPM change 7 pp 83% evidence | 17.6/25 ROCE 21.4% · OPM 14% 95% evidence | 13.9/20 P/E 9.1× · PEG — 50% evidence | 18.4/20 RS sector 30.1% · RS bench 57.6% · 1Y 46.1%10 of 12 weeks ahead 100% evidence |
| Exact sum: 28 + 17.6 + 13.9 + 18.4 = 77.9 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Khazanchi Jewellers Ltd543953 | 72.3/100Favorable setup72% evidence | TURNING | 26.5/35 Revenue 15.7% · PAT 100% · OPM change 3.9 pp 83% evidence | 18.5/25 ROCE 34.8% · OPM 7% 76% evidence | 13.5/20 P/E 20× · PEG — 50% evidence | 13.8/20 RS sector 13.2% · RS bench 5.2% · 1Y 20%1 of 10 weeks ahead 70% evidence |
| Exact sum: 26.5 + 18.5 + 13.5 + 13.8 = 72.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3Senco Gold LtdSENCO | 71.3/100Favorable setup90% evidence | TURNING | 28.8/35 Revenue 33.2% · PAT 100% · OPM change 5 pp 88% evidence | 15.3/25 ROCE 20.9% · OPM 14% 100% evidence | 15.1/20 P/E 11.5× · PEG 1.35 100% evidence | 12.1/20 RS sector -1.1% · RS bench 18.8% · 1Y 18.6%9 of 11 weeks ahead 70% evidence |
| Exact sum: 28.8 + 15.3 + 15.1 + 12.1 = 71.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Sky Gold & Diamonds LtdSKYGOLD | 68.7/100Favorable setup93% evidence | LEADER | 26.0/35 Revenue 77.4% · PAT 100% · OPM change 1 pp 83% evidence | 16.7/25 ROCE 27% · OPM 7% 95% evidence | 8.0/20 P/E 36.2× · PEG 1.71 100% evidence | 18.0/20 RS sector 35.8% · RS bench 63.5% · 1Y 113.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 26 + 16.7 + 8 + 18 = 68.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 5Utssav CZ Gold Jewels LtdUTSSAV | 67.1/100Thin evidence · provisional56% evidence | LEADER | 19.6/35 Revenue — · PAT — · OPM change 0 pp 26% evidence | 17.9/25 ROCE 28.8% · OPM 7% 95% evidence | 9.7/20 P/E 21.2× · PEG — 15% evidence | 19.9/20 RS sector 65.4% · RS bench 98% · 1Y 136%12 of 12 weeks ahead 100% evidence |
| Exact sum: 19.6 + 17.9 + 9.7 + 19.9 = 67.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Thangamayil Jewellery LtdTHANGAMAYL | 62.7/100Mixed-positive evidence100% evidence | LEADER | 26.9/35 Revenue 83.2% · PAT 100% · OPM change -1 pp 100% evidence | 13.3/25 ROCE 25.5% · OPM 5% 100% evidence | 9.8/20 P/E 41.4× · PEG 0.77 100% evidence | 12.7/20 RS sector 18.4% · RS bench 42.3% · 1Y 185%11 of 12 weeks ahead 100% evidence |
| Exact sum: 26.9 + 13.3 + 9.8 + 12.7 = 62.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Shanti Gold International LtdSHANTIGOLD | 61.0/100Mixed-positive evidence70% evidence | TURNING | 22.3/35 Revenue 82.5% · PAT 100% · OPM change 3 pp 83% evidence | 20.1/25 ROCE 33.5% · OPM 10% 95% evidence | 11.1/20 P/E 11.2× · PEG — 15% evidence | 7.5/20 RS sector -16.8% · RS bench 1.5% · 1Y -5.2%9 of 12 weeks ahead 70% evidence |
| Exact sum: 22.3 + 20.1 + 11.1 + 7.5 = 61 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Kalyan Jewellers India LtdKALYANKJIL | 57.7/100Mixed-positive evidence96% evidence | TURNING | 23.8/35 Revenue 42.7% · PAT 89% · OPM change 1 pp 88% evidence | 11.4/25 ROCE 20.5% · OPM 7% 100% evidence | 5.6/20 P/E 45.9× · PEG 2.19 100% evidence | 16.9/20 RS sector 9.7% · RS bench 33.5% · 1Y 3.1%3 of 12 weeks ahead 100% evidence |
| Exact sum: 23.8 + 11.4 + 5.6 + 16.9 = 57.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Vaibhav Global LtdVAIBHAVGBL | 57.7/100Mixed-positive evidence90% evidence | TURNING | 18.2/35 Revenue 9.3% · PAT 74.5% · OPM change 2 pp 88% evidence | 13.2/25 ROCE 16.4% · OPM 9% 100% evidence | 16.6/20 P/E 16.6× · PEG 0.33 100% evidence | 9.7/20 RS sector -6.5% · RS bench 14.1% · 1Y 14.4%5 of 10 weeks ahead 70% evidence |
| Exact sum: 18.2 + 13.2 + 16.6 + 9.7 = 57.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Uday Jewellery Industries Ltd539518 | 57.1/100Mixed-positive evidence78% evidence | 27.6/35 Revenue 100% · PAT 100% · OPM change 3 pp 83% evidence | 14.6/25 ROCE 22.4% · OPM 7% 76% evidence | 12.1/20 P/E 13.7× · PEG — 50% evidence | 2.8/20 RS sector -19.1% · RS bench -3.8% · 1Y -4.7%9 of 10 weeks ahead 100% evidence | |
| Exact sum: 27.6 + 14.6 + 12.1 + 2.8 = 57.1 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -19.1% and the one-year return is -4.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 11RBZ Jewellers LtdRBZJEWEL | 55.6/100Mixed-positive evidence83% evidence | TURNING | 19.1/35 Revenue 20% · PAT 41% · OPM change 0 pp 83% evidence | 14.9/25 ROCE 21.8% · OPM 11% 95% evidence | 13.8/20 P/E 10.9× · PEG — 50% evidence | 7.8/20 RS sector -12.3% · RS bench 6.9% · 1Y 9.7%6 of 12 weeks ahead 100% evidence |
| Exact sum: 19.1 + 14.9 + 13.8 + 7.8 = 55.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12P N Gadgil Jewellers LtdPNGJL | 54.4/100Mixed-positive evidence93% evidence | TURNING | 26.1/35 Revenue 47.8% · PAT 76.6% · OPM change 2 pp 100% evidence | 12.6/25 ROCE 20.9% · OPM 8% 100% evidence | 8.6/20 P/E 20.3× · PEG 1.77 65% evidence | 7.1/20 RS sector -9.8% · RS bench 10.1% · 1Y 15.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 26.1 + 12.6 + 8.6 + 7.1 = 54.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Shringar House of Mangalsutra LtdSHRINGARMS | 53.2/100Thin evidence · provisional56% evidence | BREAKING OUT | 17.3/35 Revenue 57.2% · PAT 90.2% · OPM change -1 pp 83% evidence | 15.8/25 ROCE 26.8% · OPM 6% 95% evidence | 10.1/20 P/E 18.6× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —6 of 12 weeks ahead 0% evidence |
| Exact sum: 17.3 + 15.8 + 10.1 + 10 = 53.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Titan Company LtdTITAN | 51.8/100Mixed-positive evidence96% evidence | TURNING | 19.1/35 Revenue 44.9% · PAT 52% · OPM change -3 pp 88% evidence | 14.9/25 ROCE 20.5% · OPM 7% 100% evidence | 8.5/20 P/E 84× · PEG 1.43 100% evidence | 9.3/20 RS sector -2.6% · RS bench 18.6% · 1Y 40.9%1 of 12 weeks ahead 100% evidence |
| Exact sum: 19.1 + 14.9 + 8.5 + 9.3 = 51.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Golkunda Diamonds & Jewellery Ltd523676 | 51.7/100Thin evidence · provisional57% evidence | 13.3/35 Revenue 1.3% · PAT -12.4% · OPM change -0.8 pp 53% evidence | 13.4/25 ROCE 19.9% · OPM 9.7% 57% evidence | 8.9/20 P/E 16× · PEG — 50% evidence | 16.1/20 RS sector 61.7% · RS bench 52.8% · 1Y 53.4%9 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 13.3 + 13.4 + 8.9 + 16.1 = 51.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16D.P. Abhushan LtdDPABHUSHAN | 50.9/100Mixed-positive evidence100% evidence | TURNING | 21.3/35 Revenue 9.4% · PAT 79.6% · OPM change 0.7 pp 100% evidence | 15.3/25 ROCE 24.4% · OPM 10.7% 100% evidence | 4.7/20 P/E 74.2× · PEG 1.87 100% evidence | 9.6/20 RS sector -16.9% · RS bench 1.6% · 1Y -21.5%3 of 12 weeks ahead 100% evidence |
| Exact sum: 21.3 + 15.3 + 4.7 + 9.6 = 50.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17PNGS Gargi Fashion Jewellery Ltd543709 | 47.4/100Mixed-negative evidence76% evidence | ASLEEP | 8.4/35 Revenue 18.3% · PAT 8.7% · OPM change -3.5 pp 95% evidence | 20.7/25 ROCE 33.8% · OPM 19.8% 76% evidence | 10.7/20 P/E 21.2× · PEG — 50% evidence | 7.6/20 RS sector -2.3% · RS bench -30.5% · 1Y -27.9%1 of 10 weeks ahead 70% evidence |
| Exact sum: 8.4 + 20.7 + 10.7 + 7.6 = 47.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Bluestone Jewellery & Lifestyle LtdBLUESTONE | 46.4/100Thin evidence · provisional54% evidence | TURNING | 23.5/35 Revenue 40% · PAT 100% · OPM change 3.4 pp 74% evidence | 4.4/25 ROCE 7.1% · OPM 14.5% 100% evidence | 8.5/20 P/E 221× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y 49.4%7 of 10 weeks ahead 0% evidence |
| Exact sum: 23.5 + 4.4 + 8.5 + 10 = 46.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19PC Jeweller LtdPCJEWELLER | 43.3/100Mixed-negative evidence90% evidence | ASLEEP | 14.5/35 Revenue 49.4% · PAT 23.7% · OPM change -3 pp 88% evidence | 8.2/25 ROCE 9.6% · OPM 18% 100% evidence | 16.2/20 P/E 12.6× · PEG 0.26 100% evidence | 4.4/20 RS sector -22.2% · RS bench -12.7% · 1Y -36.4%1 of 11 weeks ahead 70% evidence |
| Exact sum: 14.5 + 8.2 + 16.2 + 4.4 = 43.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 20Radhika Jeweltech LtdRADHIKAJWE | 43.3/100Mixed-negative evidence83% evidence | TURNING | 11.6/35 Revenue 8.7% · PAT 30% · OPM change -6.7 pp 83% evidence | 14.3/25 ROCE 25.1% · OPM 5.7% 95% evidence | 10.7/20 P/E 11.3× · PEG — 50% evidence | 6.7/20 RS sector -20.8% · RS bench -3.1% · 1Y -27.2%1 of 12 weeks ahead 100% evidence |
| Exact sum: 11.6 + 14.3 + 10.7 + 6.7 = 43.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21Motisons Jewellers LtdMOTISONS | 42.0/100Mixed-negative evidence83% evidence | FADING | 13.4/35 Revenue 5.9% · PAT 47.6% · OPM change -9.4 pp 83% evidence | 12.8/25 ROCE 17.9% · OPM 6.1% 95% evidence | 11.8/20 P/E 25.3× · PEG — 50% evidence | 4.0/20 RS sector -24.3% · RS bench -7.5% · 1Y -33.4%2 of 12 weeks ahead 100% evidence |
| Exact sum: 13.4 + 12.8 + 11.8 + 4 = 42 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Manoj Vaibhav Gems N Jewellers LtdMVGJL | 40.1/100Mixed-negative evidence83% evidence | ASLEEP | 12.6/35 Revenue 15.1% · PAT 13.9% · OPM change -1 pp 83% evidence | 10.1/25 ROCE 15.6% · OPM 5% 95% evidence | 14.1/20 P/E 7.1× · PEG — 50% evidence | 3.3/20 RS sector -22.3% · RS bench -5% · 1Y -22.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 12.6 + 10.1 + 14.1 + 3.3 = 40.1 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 23Asian Star Company Ltdthis pageASTAR | 27.8/100Adverse evidence75% evidence | ASLEEP | 12.0/35 Revenue -2.5% · PAT -2.5% · OPM change 0.2 pp 62% evidence | 7.2/25 ROCE 3.6% · OPM 0.8% 95% evidence | 6.8/20 P/E 23.6× · PEG — 50% evidence | 1.8/20 RS sector -27.2% · RS bench -10.9% · 1Y -21%2 of 12 weeks ahead 100% evidence |
| Exact sum: 12 + 7.2 + 6.8 + 1.8 = 27.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Rajesh Exports LtdRAJESHEXPO | 26.8/100Adverse evidence96% evidence | ASLEEP | 16.3/35 Revenue 84% · PAT 15.6% · OPM change -0.1 pp 88% evidence | 4.4/25 ROCE 1.9% · OPM -0.1% 100% evidence | 5.8/20 P/E 22.3× · PEG 1.74 100% evidence | 0.3/20 RS sector -53.8% · RS bench -43.2% · 1Y -56.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 4.4 + 5.8 + 0.3 = 26.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25PNGS Reva Diamond Jewellery LimitedPNGSREVA | 60.0/100Thin evidence · provisional43% evidence | ASLEEP | 23.5/35 Revenue — · PAT — · OPM change 7 pp 45% evidence | 16.1/25 ROCE 22% · OPM 29% 95% evidence | 10.4/20 P/E 16.1× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —0 of 3 weeks ahead 0% evidence |
| Exact sum: 23.5 + 16.1 + 10.4 + 10 = 60 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26SJ Corporation Ltd504398 | 42.1/100Thin evidence · provisional28% evidence | TURNING | 16.0/35 Revenue — · PAT — · OPM change -5.2 pp 10% evidence | 3.6/25 ROCE 0.1% · OPM -4.8% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.5/20 RS sector — · RS bench 175.1% · 1Y —3 of 3 weeks ahead 25% evidence |
| Exact sum: 16 + 3.6 + 10 + 12.5 = 42.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Asian Star Company Ltd's share price today?
Asian Star Company Ltd trades at ₹595, −18.5% over the past year. The company is valued at ₹952 Cr. The stock sits at 9% of its 52-week range of ₹580–₹744, −5.1% versus its 200-day average. On the tape, the price is topping out, 4 weeks in. — as of 31 July 2026.
What were Asian Star Company Ltd's latest quarterly results?
Asian Star Company Ltd reported revenue of ₹746 Cr and a net loss of ₹0.4 Cr for the Mar 26 quarter. Earnings per share were ₹−0.25. The operating margin was 0.8%, 0.2 pp higher than a year earlier. — as of 31 July 2026.
What is Asian Star Company Ltd's revenue?
Asian Star Company Ltd reported revenue of ₹746 Cr in the Mar 26 quarter, −12.7% year on year. For the full FY26 fiscal year, revenue was ₹2,882 Cr (−2.5%). Over the last 10 years revenue compounded at −1.4% a year. — as of 31 July 2026.
What is Asian Star Company Ltd's profit?
Asian Star Company Ltd earned ₹−0.4 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹40.0 Cr. The operating margin ran 0.8% in the latest quarter. — as of 31 July 2026.
What is Asian Star Company Ltd's market cap?
Asian Star Company Ltd's market capitalisation is ₹952 Cr at a share price of ₹595. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Asian Star Company Ltd's P/E ratio?
Asian Star Company Ltd trades at a P/E of 23.6×, at the 73rd percentile of its own 10-year range, against a long-run median of 16.5×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Asian Star Company Ltd pay a dividend?
Yes — Asian Star Company Ltd's dividend payout was 6% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is Asian Star Company Ltd overvalued?
On its own history, Asian Star Company Ltd looks expensive against its own history: its P/E of 23.6× sits at the 73rd percentile of its 10-year range (long-run median 16.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
How is Asian Star Company Ltd performing?
Asian Star Company Ltd is topping out, 4 weeks in. Against the NIFTY 500 it has been behind on a trailing-13-week view for 6 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is Asian Star Company Ltd in?
Turning around — profit growth swung from −38.9% at the trough to −15.6% off a 3-quarter-old trough (single-quarter readings), ROCE slipping at 4.0%. The read comes from the last 12 quarters of growth (revenue growth −12.7% latest, profit growth −15.6% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is Asian Star Company Ltd in an uptrend?
It is stalling — the price is topping out (week 4 of stage 3), trading −5.1% versus its 200-day average and at 9% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Asian Star Company Ltd beating the market?
Not lately — on a trailing-13-week view Asian Star Company Ltd is currently behind the NIFTY 500 (6 weeks and counting; last ahead the week of 2026-06-25), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved −13% against the NIFTY 500's +264% — behind the index over the full window. — as of 31 July 2026.
Will Asian Star Company Ltd's share price go up?
This page publishes no price forecast for Asian Star Company Ltd. What it measures instead: the share price is ₹595, the price is topping out 4 weeks in. Its P/E of 23.6× sits at the 73rd percentile of its own 10-year range. — as of 31 July 2026.
Who owns Asian Star Company Ltd?
Promoters hold 74.7% of Asian Star Company Ltd, foreign institutions null%, domestic institutions 4.2% and the public 21.1% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 31 July 2026.
Does Asian Star Company Ltd have too much debt?
No — Asian Star Company Ltd's debt-to-equity is 0.30, and operating profit covers the interest bill 3×. FY26 borrowings were ₹493 Cr against equity of ₹1,658 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.
What is Asian Star Company Ltd's capex?
Asian Star Company Ltd spent ₹21.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹4.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Asian Star Company Ltd's cash flow?
Asian Star Company Ltd generated ₹90.0 Cr of operating cash flow in FY26 and ₹86.0 Cr of free cash flow after ₹4.0 Cr of capital spending. Reported profit that year was ₹40.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Asian Star Company Ltd's profit real cash?
Yes — over the last 3 fiscal years, 159% of Asian Star Company Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹90.0 Cr against reported profit of ₹40.0 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 31 July 2026.
Where is Asian Star Company Ltd in its business cycle?
Asian Star Company Ltd's FY26 operating margin was 2.2%, against a 13-year band of 2.2%–5.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 0.8%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Asian Star Company Ltd story?
Biggest watch item: the P/E sits at the 73rd percentile of its own range — the multiple has already done part of the work. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Asian Star Company Ltd a stock worth studying right now?
This is not investment advice. The machine read: Asian Star Company Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.